APA (7th ed.) Citation

EJ, H., JM, M., F, K., FJ, A., E, A., M, L., . . . S, A. (2022). Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: A retrospective surveillance study. The Lancet. Infectious diseases, 22(3), 357. https://doi.org/10.1016/S1473-3099(21)00566-1

Chicago Style (17th ed.) Citation

EJ, Haas, et al. "Infections, Hospitalisations, and Deaths Averted via a Nationwide Vaccination Campaign Using the Pfizer-BioNTech BNT162b2 MRNA COVID-19 Vaccine in Israel: A Retrospective Surveillance Study." The Lancet. Infectious Diseases 22, no. 3 (2022): 357. https://doi.org/10.1016/S1473-3099(21)00566-1.

MLA (9th ed.) Citation

EJ, Haas, et al. "Infections, Hospitalisations, and Deaths Averted via a Nationwide Vaccination Campaign Using the Pfizer-BioNTech BNT162b2 MRNA COVID-19 Vaccine in Israel: A Retrospective Surveillance Study." The Lancet. Infectious Diseases, vol. 22, no. 3, 2022, p. 357, https://doi.org/10.1016/S1473-3099(21)00566-1.